Cleared Traditional

K031135 - GLUCOSE FLEX REAGENT CARTRIDGE (GLUC)

K031135 is the FDA 510(k) clearance for GLUCOSE FLEX REAGENT CARTRIDGE (GLUC) by Dade Behring, Inc.. It is a Class 2 Chemistry device (product code CFR) cleared through the Traditional 510(k) pathway after a 54-day FDA review.

K031135 · Dade Behring, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2003
Decision
54d
Days
Class 2
Risk

K031135 is an FDA 510(k) clearance for the GLUCOSE FLEX REAGENT CARTRIDGE (GLUC). Classified as Hexokinase, Glucose (product code CFR), Class II - Special Controls.

Submitted by Dade Behring, Inc. (Newark, US). The FDA issued a Cleared decision on June 2, 2003 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dade Behring, Inc. devices

Submission Details

510(k) Number K031135 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 09, 2003
Decision Date June 02, 2003
Days to Decision 54 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 88d · This submission: 54d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CFR Hexokinase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CFR Hexokinase, Glucose

All 100
Devices cleared under the same product code (CFR) and FDA review panel - the closest regulatory comparables to K031135.
UNICEL DXC 600I SYNCHRON ACCESS CLINICAL SYSTEM
K060256 · Beckman Coulter, Inc. · Feb 2006
ADVIA IMS GLUCOSE ASSAY
K052163 · Bayer Healthcare, LLC · Oct 2005
RAICHEM GLUCOSE UV (LIQUID)
K041052 · Hemagen Diagnostics, Inc. · Jun 2004
WAKO L-TYPE GLUCOSE 2
K024281 · Wako Chemicals USA, Inc. · Feb 2003
GLUCOSE-SL-C ASSAY, MODEL 257-30
K023739 · Diagnostic Chemicals , Ltd. · Jan 2003
ADVIA 1650 GLUCOSE HEXOKINASE 11 ASSAY
K011963 · Bayer Corp. · Nov 2001